Becton, Dickinson And Company is a healthcare company focusing on drug delivery improvement, infectious disease and cancer diagnosis enhancement, diabetes management support, and cellular research advancement. Founded in 1897 and based in the state of New Jersey, the company has grown to become an industry leader with a diverse workforce of over 76,000 associates across 50 countries. The company's mission aims to help all people live healthy lives by advancing the quality, accessibility, safety, and affordability of healthcare worldwide.
The CEO of Becton, Dickinson and Company is Thomas E. Polen and the company generates an annual revenue of $18.9 billion. Some prominent products offered by Becton, Dickinson and Company include medical devices, laboratory equipment, and diagnostic systems. Their innovative solutions have made significant contributions to addressing pressing global health needs and improving patient outcomes.